BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 31097746)

  • 1. Mortality due to Cryptococcus neoformans and Cryptococcus gattii in low-income settings: an autopsy study.
    Hurtado JC; Castillo P; Fernandes F; Navarro M; Lovane L; Casas I; Quintó L; Marco F; Jordao D; Ismail MR; Lorenzoni C; Martinez-Palhares AE; Ferreira L; Lacerda M; Monteiro W; Sanz A; Letang E; Marimon L; Jesri S; Cossa A; Mandomando I; Vila J; Bassat Q; Ordi J; Menéndez C; Carrilho C; Martínez MJ
    Sci Rep; 2019 May; 9(1):7493. PubMed ID: 31097746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.
    Chowdhary A; Randhawa HS; Sundar G; Kathuria S; Prakash A; Khan Z; Sun S; Xu J
    J Med Microbiol; 2011 Jul; 60(Pt 7):961-967. PubMed ID: 21393452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical insights and epidemiology of central nervous system infection due to Cryptococcus neoformans/gattii species complexes: A prospective study from South India.
    Lahiri S; Manjunath N; Bhat M; Hagen F; Bahubali VH; Palaniappan M; Maji S; Chandrashekar N
    Med Mycol; 2020 Jul; 58(5):600-608. PubMed ID: 31578566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptococcus tetragattii as a major cause of cryptococcal meningitis among HIV-infected individuals in Harare, Zimbabwe.
    Nyazika TK; Hagen F; Meis JF; Robertson VJ
    J Infect; 2016 Jun; 72(6):745-752. PubMed ID: 27038502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptococcosis in HIV/AIDS patients in northern Brazil: Clinical aspects, molecular types and isolation of agents from environmental samples associated with patients.
    Alves MJ; do Nascimento IS; Cruz KS; Menescal VVF; Menescal LSF; Silva LSC; Pinheiro SB; Gómez ASP; de Souza JVB; Lazera MDS; Jackisch-Matsuura AB
    Trop Med Int Health; 2022 Apr; 27(4):387-396. PubMed ID: 35178835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and microbiological characteristics of cryptococcosis in Singapore: predominance of Cryptococcus neoformans compared with Cryptococcus gattii.
    Chan M; Lye D; Win MK; Chow A; Barkham T
    Int J Infect Dis; 2014 Sep; 26():110-5. PubMed ID: 25018090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial Quantification of the Population Exposed to Cryptococcus neoformans and Cryptococcus gattii Species Complexes in Europe: Estimating the Immunocompetent and HIV/AIDS Patients Under Risk.
    Alaniz AJ; Carvajal JG; Carvajal MA; Cogliati M; Vergara PM
    Risk Anal; 2020 Mar; 40(3):524-533. PubMed ID: 31578757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Landmark clinical observations and immunopathogenesis pathways linked to HIV and Cryptococcus fatal central nervous system co-infection.
    Okurut S; Boulware DR; Olobo J; Meya DB
    Mycoses; 2020 Aug; 63(8):840-853. PubMed ID: 32472727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological, Clinical and Outcome Aspects of Patients with Cryptococcosis Caused by Cryptococcus gattii from a Non-endemic Area of Brazil.
    Damasceno-Escoura AH; de Souza ML; de Oliveira Nunes F; Pardi TC; Gazotto FC; Florentino DH; Mora DJ; Silva-Vergara ML
    Mycopathologia; 2019 Feb; 184(1):65-71. PubMed ID: 30415450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptococcus gattii Species Complex as an Opportunistic Pathogen: Underlying Medical Conditions Associated with the Infection.
    Yang DH; England MR; Salvator H; Anjum S; Park YD; Marr KA; Chu LA; Govender NP; Lockhart SR; Desnos-Ollivier M; Chen S; Halliday C; Kan A; Chen J; Wollenberg KR; Zelazny A; Perfect JR; Chang YC; Bennett JE; Holland SM; Meyer W; Williamson PR; Kwon-Chung KJ
    mBio; 2021 Oct; 12(5):e0270821. PubMed ID: 34700378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular types of Cryptococcus gattii/Cryptococcus neoformans species complex from clinical and environmental sources in Nairobi, Kenya.
    Kangogo M; Bader O; Boga H; Wanyoike W; Folba C; Worasilchai N; Weig M; Groß U; Bii CC
    Mycoses; 2015 Nov; 58(11):665-70. PubMed ID: 26404188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods.
    Nishikawa MM; Almeida-Paes R; Brito-Santos F; Nascimento CR; Fialho MM; Trilles L; Morales BP; da Silva SA; Santos W; Santos LO; Fortes ST; Cardarelli-Leite P; Lázera MDS
    Med Mycol; 2019 Oct; 57(7):864-873. PubMed ID: 30657975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular typing of clinical isolates of Cryptococcus neoformans/Cryptococcus gattii species complex from Northeast Mexico.
    González GM; Casillas-Vega N; Garza-González E; Hernández-Bello R; Rivera G; Rodríguez JA; Bocanegra-Garcia V
    Folia Microbiol (Praha); 2016 Jan; 61(1):51-6. PubMed ID: 26109075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotypes of Cryptococcus neoformans and Cryptococcus gattii as agents of endemic cryptococcosis in Teresina, Piauí (northeastern Brazil).
    Martins LM; Wanke B; Lazéra Mdos S; Trilles L; Barbosa GG; Macedo RC; Cavalcanti Mdo A; Eulálio KD; Castro JA; Silva AS; Nascimento FF; Gouveia VA; Monte SJ
    Mem Inst Oswaldo Cruz; 2011 Sep; 106(6):725-30. PubMed ID: 22012227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular types of Cryptococcus neoformans and Cryptococcus gattii in Western Australia and correlation with antifungal susceptibility.
    Lee GA; Arthur I; Merritt A; Leung M
    Med Mycol; 2019 Nov; 57(8):1004-1010. PubMed ID: 30649538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Cryptococcus gattii in Ugandan HIV-infected patients presenting with cryptococcal meningitis.
    Wembabazi A; Nassozi DR; Akot E; Ochola TI; Kweka PT; Katamu NT; Meya D; Achan B
    PLoS One; 2022; 17(7):e0270597. PubMed ID: 35839221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Method for identification of Cryptococcus neoformans and Cryptococcus gattii useful in resource-limited settings.
    Ogundeji AO; Albertyn J; Pohl CH; Sebolai OM
    J Clin Pathol; 2016 Apr; 69(4):352-7. PubMed ID: 26598625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cryptococcosis caused by Cryptococcus neoformans var. Gattii. A case associated with acquired immunodeficiency syndrome (AIDS) in Kinshasa, Zaire].
    Muyembe Tamfum JJ; Mupapa Kibadi D; Nganda L; Ngwala-Bikindu D; Kuezina T; Kela-We I; Vandepitte J
    Med Trop (Mars); 1992; 52(4):435-8. PubMed ID: 1494313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiological, epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997-2010.
    Tseng HK; Liu CP; Ho MW; Lu PL; Lo HJ; Lin YH; Cho WL; Chen YC;
    PLoS One; 2013; 8(4):e61921. PubMed ID: 23613973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptococcal infections in children: retrospective study and review from Australia.
    Grimshaw A; Palasanthiran P; Huynh J; Marais B; Chen S; McMullan B
    Future Microbiol; 2019 Dec; 14():1531-1544. PubMed ID: 31992070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.